Head to head for first-timers
CoreAge Rx vs Ozi
CoreAge Rx and Ozi both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxOzi
Rank #271 for first-timers · Grade C
Mama-Match
Best for: If you will budget $279 from week five and have already decided whether paying for a block up front suits you.
Visit OziThe verdict for a first step
CoreAge Rx edges out Ozi on the Mama-Match Score, 73 to 44 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Ozi is still a genuine option — budget $279, not $139. Ozi's line says "$139 for your first 4 weeks, then $279/mo", and the badge above that very same offer calls it "first month 50% off" — four weeks in one place and a month in the other, and either way the price roughly doubles when it ends. Tirzepatide does the same at $189 then $379. The longer plans do cut it properly, 22% at twelve weeks and 47% at fifty-two, but you pay for the whole block at once and it ships every four weeks, so you trade flexibility for the discount. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Ozi |
|---|---|---|
| Mama-Match Score | 73/100 · C | 44/100 · C |
| Overall rank | #31 | #271 |
| Semaglutide | $99/mo | $279/mo after the introductory period |
| Tirzepatide | $149/mo | $379/mo after the introductory period |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not stated on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
Ozi
Rank #271 · Grade C
What we like
- It puts the ongoing price right beside the introductory one instead of leaving it for the invoice
- The longer plans are genuinely cheaper — 22%, 29% and 47% off
- It names who handles the clinical side rather than only saying "licensed providers"
The caveats
- The price roughly doubles after the introductory period — $139 to $279, and $189 to $379 for tirzepatide
- The introductory period is four weeks but the ongoing rate is per month, and the badge calls it a month too
- The cheaper long plans are paid all at once, so you lose the ability to stop
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Ozi with the other providers we review for women.
Or browse the full comparison hub.